|Podcasts|February 1, 2013
Challenges with Oncology Trials in Ontario
Advertisement
Karen Arts
Karen Arts, Director of Business Development, High Impact Clinical Trials Program at the Ontario Institute for Cancer Research in Toronto, Canada discusses challenges in oncology trials in Ontario with Roberto Lara, Director of Business Development for Scimega Research.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE SummitFebruary 7th 2025
The MDR: Navigating Europe’s New Standard for Medical Device SafetyOctober 25th 2022
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Investigational PD-L1 x VEGF-A Bispecific Antibody Demonstrates Strong Overall Response Rate in Phase II Small Cell Lung Cancer Trial
2
FDA Fast Tracks Sanofi’s Intravitreal Gene Therapy for Neovascular Age-Related Macular Degeneration
3
How Recent Policy Changes Could Impact Clinical Research
4
Phase III BRUIN CLL-313 Trial Finds Jaypirca Extends Progression-Free Survival in Treatment-Naïve CLL/SLL
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
